Identification Of Key Genes Modules Linking Brain Aging Signatures And COVID-19-Associated Cognitive Impairment

Aging Pathway
Therapeutic
Analytical
A study identified key genes linking brain aging signatures and COVID-19-associated cognitive impairment and suggested several potential drug compounds that may be beneficial.
Author

Gemini

Published

March 10, 2026

Many people who have had COVID-19 experience “brain fog” and memory issues, suggesting a link between the virus and cognitive decline. Researchers have been working to understand the molecular changes behind these neurological symptoms. A recent study used advanced computational methods to analyze how gene activity in the brain changes after COVID-19 infection. They found that genes important for brain cell communication and function were less active, while genes involved in immune responses were more active. This pattern of gene activity showed striking similarities to what is observed in the aging brain. The study pinpointed five specific genes (SST, S100A9, SOSC3, FKBP5, and HBB) that appear to be central to this connection between COVID-19 and brain aging. Furthermore, by understanding these key genes, the researchers were able to identify seven existing compounds—Fulvestrant, Bucladesine, S-Adenosylmethionine, Valproic Acid, Folic Acid, Kaempferol, and Quercetin—that could potentially help mitigate COVID-19-related cognitive impairment by targeting these specific genes. It’s important to remember that these findings are based on computer simulations and require further testing in real-world biological systems to confirm their effectiveness.


Source: link to paper